{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:20:35Z","timestamp":1774498835975,"version":"3.50.1"},"reference-count":52,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Psoriatic arthritis (PsA) is a chronic rheumatic disease that is frequently associated with fibromyalgia (FM). The coexistence of FM complicates the evaluation of PsA disease activity and the planning of treatment strategies, as the two conditions share many overlapping clinical symptoms. To investigate the contribution of demographic factors and available serum biomarkers of inflammation and autoimmunity in characterizing the heterogeneity among patients meeting the classification criteria for both PsA and FM. Materials and Methods: This cross-sectional, single-center study involved 1547 adult patients evaluated between January 2017 and December 2024 who met the CASPAR criteria for PsA. A patient subgroup also met the 2016 ACR criteria for FM. Demographic data, serum inflammatory markers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), and autoimmunity markers including antinuclear antibodies (ANA), rheumatoid factor (RF), and anti-citrullinated protein antibodies (ACPA) were evaluated. Statistical analyses included chi-square tests, t-tests, Mann\u2013Whitney U tests, and multivariate logistic regression to identify independent predictors associated with the coexistence of PsA and FM. Results: A total of 254 patients (16.42%) were diagnosed with concomitant FM. Compared to patients with PsA alone, those with concurrent PsA and FM showed significantly lower C-reactive protein (CRP) levels (0.39 \u00b1 0.74 vs. 2.88 \u00b1 12.31 mg\/dL; p &lt; 0.001) and a higher frequency of antinuclear antibody (ANA) positivity (13.57% vs. 5.78%; p &lt; 0.001). No significant differences were observed in rheumatoid factor (RF) or anti-citrullinated protein antibody (ACPA) positivity between the groups. Multivariate logistic regression identified female sex, ANA positivity, CRP levels \u2264 0.5 mg\/dL, and elevated body mass index (BMI) as independent predictors of the presence of concomitant FM. Conclusions: Patients with concomitant PsA and FM have a distinct demographic and serological profile, suggesting the existence of a clinically significant subgroup within the PsA population. Recognition of these differences may improve diagnostic accuracy and support the development of personalized, non-immunosuppressive therapeutic strategies for this subgroup of patients.<\/jats:p>","DOI":"10.3390\/medicina61061050","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T09:02:03Z","timestamp":1749200523000},"page":"1050","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Demographic Characteristics and Inflammatory Biomarker Profile in Psoriatic Arthritis Patients with Comorbid Fibromyalgia: A Cross-Sectional Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-9128","authenticated-orcid":false,"given":"Marino","family":"Paroli","sequence":"first","affiliation":[{"name":"Clinical Immunology Unit, Department of Clinical Immunology, Department of Clinical, Anesthesiologic and Cardiovascular Sciences, Istituto Chirurgico Ortopedico Traumatologico (ICOT), Sapienza University of Rome, 04100 Latina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3559-2571","authenticated-orcid":false,"given":"Chiara","family":"Gioia","sequence":"additional","affiliation":[{"name":"Internal Medicine Division, Department of Clinical Immunology, Department of Clinical, Anesthesiologic and Cardiovascular Sciences, Policlinico Umberto I University Hospital, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0983-3610","authenticated-orcid":false,"given":"Daniele","family":"Accapezzato","sequence":"additional","affiliation":[{"name":"Internal Medicine Division, Department of Clinical Immunology, Department of Clinical, Anesthesiologic and Cardiovascular Sciences, Policlinico Umberto I University Hospital, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalba","family":"Caccavale","sequence":"additional","affiliation":[{"name":"Clinical Immunology Unit, Department of Clinical Immunology, Department of Clinical, Anesthesiologic and Cardiovascular Sciences, Istituto Chirurgico Ortopedico Traumatologico (ICOT), Sapienza University of Rome, 04100 Latina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41572-021-00293-y","article-title":"Psoriatic arthritis","volume":"7","author":"FitzGerald","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41584-021-00692-1","article-title":"Fatigue in inflammatory rheumatic diseases: Current knowledge and areas for future research","volume":"17","author":"Davies","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00296-024-05780-5","article-title":"Sleep disorders in rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis","volume":"45","author":"Polak","year":"2025","journal-title":"Rheumatol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s40744-020-00207-6","article-title":"Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation","volume":"7","author":"Mathew","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","article-title":"Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment","volume":"16","author":"Giorgi","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/j.pain.0000000000001384","article-title":"Chronic pain as a symptom or a disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11)","volume":"160","author":"Treede","year":"2019","journal-title":"Pain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/ard-2023-225327","article-title":"From fibrositis to fibromyalgia to nociplastic pain: How rheumatology helped get us here and where do we go from here?","volume":"83","author":"Clauw","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: Towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e144201","DOI":"10.1172\/JCI144201","article-title":"Passive transfer of fibromyalgia symptoms from patients to mice","volume":"131","author":"Goebel","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105397","DOI":"10.1016\/j.jbspin.2022.105397","article-title":"Is fibromyalgia an immune-mediated disease?","volume":"89","author":"Trouvin","year":"2022","journal-title":"Joint Bone Spine"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Paroli, M., Gioia, C., Accapezzato, D., and Caccavale, R. (2024). Inflammation, Autoimmunity, and Infection in Fibromyalgia: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115922"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10067-023-06605-9","article-title":"Difficult to treat psoriatic arthritis\u2014How should we manage?","volume":"42","author":"Kumthekar","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41584-025-01229-6","article-title":"Delineating inflammatory from non-inflammatory mechanisms for therapy optimization in psoriatic arthritis","volume":"21","author":"Zabotti","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"101970","DOI":"10.1016\/j.berh.2024.101970","article-title":"\u201cInflammatory or non-inflammatory pain in inflammatory arthritis\u2014How to differentiate it?\u201d","volume":"38","author":"Pellegrino","year":"2024","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40744-020-00202-x","article-title":"The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review","volume":"7","author":"Canete","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/acr.25358","article-title":"Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association With Disease Severity Assessment in a Large US Registry","volume":"76","author":"Mease","year":"2024","journal-title":"Arthritis. Care Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/rheumatology\/kez505","article-title":"Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis","volume":"59","author":"Iannone","year":"2020","journal-title":"Rheumatology"},{"key":"ref_18","first-page":"1150","article-title":"Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia","volume":"42","author":"Navarini","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wirth, T., Balandraud, N., Boyer, L., Lafforgue, P., and Pham, T. (2022). Biomarkers in psoriatic arthritis: A meta-analysis and systematic review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1054539"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hackshaw, K.V. (2021). The Search for Biomarkers in Fibromyalgia. Diagnostics, 11.","DOI":"10.3390\/diagnostics11020156"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1756-185X.14029","article-title":"Fibromyalgia and psoriatic arthritis: Partners together","volume":"24","author":"Littlejohn","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: Prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","article-title":"Fibromyalgia in patients with axial spondyloarthritis: Epidemiological profile and effect on measures of disease activity","volume":"34","author":"Salaffi","year":"2014","journal-title":"Rheumatol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","article-title":"Frequency of concomitant fibromyalgia in rheumatic diseases: Monocentric study of 691 patients","volume":"47","author":"Fan","year":"2017","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ejp.1252","article-title":"Comorbid fibromyalgia: A qualitative review of prevalence and importance","volume":"22","author":"Fitzcharles","year":"2018","journal-title":"Eur. J. Pain."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr. Pain. Headache Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Wolfe, F., Walitt, B., Perrot, S., Rasker, J.J., and Hauser, W. (2018). Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0203755"},{"key":"ref_30","first-page":"193","article-title":"The role of sex hormones on fibromyalgia pain mediators","volume":"14","author":"Bramwell","year":"2010","journal-title":"Int. J. Pharm. Compd."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"175696","DOI":"10.1016\/j.ejphar.2023.175696","article-title":"Spinal dopaminergic D(1)-and D(2)-like receptors have a sex-dependent effect in an experimental model of fibromyalgia","volume":"948","author":"Coffeen","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/postgradmedj-2021-140336","article-title":"Can fibromyalgia be considered a characteristic symptom of climacterium?","volume":"99","author":"Ozcivit","year":"2023","journal-title":"Postgrad. Med. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neubiorev.2017.01.039","article-title":"Age changes in pain perception: A systematic-review and meta-analysis of age effects on pain and tolerance thresholds","volume":"75","author":"Lautenbacher","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"afae107","DOI":"10.1093\/ageing\/afae107","article-title":"Age-associated changes in multimodal pain perception","volume":"53","author":"Zhi","year":"2024","journal-title":"Age Ageing"},{"key":"ref_35","first-page":"1084","article-title":"Fibromyalgia severity according to age categories: Results of a cross-sectional study from a large national database","volume":"40","author":"Farah","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.semarthrit.2021.02.007","article-title":"Fibromyalgia and obesity: A comprehensive systematic review and meta-analysis","volume":"51","author":"Ciaffi","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","article-title":"Obesity and Psoriatic Arthritis: A Narrative Review","volume":"7","author":"Kumthekar","year":"2020","journal-title":"Rheumatol. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/2359-3997000000248","article-title":"Serum levels of leptin and adiponectin and clinical parameters in women with fibromyalgia and overweight\/obesity","volume":"61","author":"Paiva","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Neumann, E., Hasseli, R., Ohl, S., Lange, U., Frommer, K.W., and Muller-Ladner, U. (2021). Adipokines and Autoimmunity in Inflammatory Arthritis. Cells, 10.","DOI":"10.3390\/cells10020216"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41584-019-0364-x","article-title":"Tendon and ligament mechanical loading in the pathogenesis of inflammatory arthritis","volume":"16","author":"Gracey","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dimino, C., Teruya, S.L., Silverman, K.D., and Mielenz, T.J. (2022). Central Obesity Is Associated With an Increased Rate of Multisite Pain in Older Adults. Front. Public. Health, 10.","DOI":"10.3389\/fpubh.2022.735591"},{"key":"ref_42","first-page":"S48","article-title":"Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review","volume":"33","author":"Smolen","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/rheumatology\/keaa766","article-title":"Measuring disease activity in psoriatic arthritis: PASDAS implementation in a tightly monitored cohort reveals residual disease burden","volume":"60","author":"Mulder","year":"2021","journal-title":"Rheumatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e001756","DOI":"10.1136\/rmdopen-2021-001756","article-title":"Systematic review of the use of CRP in clinical trials for psoriatic arthritis: A concern for clinical practice?","volume":"8","author":"Houttekiet","year":"2022","journal-title":"RMD Open"},{"key":"ref_45","first-page":"e10276","article-title":"The Influence of Pro-inflammatory Cytokines and Genetic Variants in the Development of Fibromyalgia: A Traditional Review","volume":"12","author":"Peck","year":"2020","journal-title":"Cureus"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-019-2013-9","article-title":"Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease","volume":"21","author":"Hafiz","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00296-007-0413-7","article-title":"Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up","volume":"27","author":"Kotter","year":"2007","journal-title":"Rheumatol. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s100670200118","article-title":"The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2\u20134 years\u2019 follow-up","volume":"21","author":"Ottewell","year":"2002","journal-title":"Clin. Rheumatol."},{"key":"ref_49","first-page":"376","article-title":"Anti-cyclic citrullinated peptide antibodies in psoriatic arthritis\u2014Cross-sectional study and literature review","volume":"6","author":"Popescu","year":"2013","journal-title":"J. Med. Life"},{"key":"ref_50","first-page":"1354","article-title":"Incidence and prevalence of psoriatic arthritis: A systematic review","volume":"35","author":"Alamanos","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","article-title":"Prevalence of fibromyalgia: A survey in five European countries","volume":"39","author":"Branco","year":"2010","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1136\/annrheumdis-2021-220562","article-title":"Role of ultrasound for assessment of psoriatic arthritis patients with fibromyalgia","volume":"80","author":"Polachek","year":"2021","journal-title":"Ann. Rheum. Dis."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1050\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:47:44Z","timestamp":1760032064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/6\/1050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["medicina61061050"],"URL":"https:\/\/doi.org\/10.3390\/medicina61061050","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}